Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 9-Month ad blackout help problem gamblers stay away?

NCT ID NCT05413564

Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether extending the time gambling websites stop sending ads after a person voluntarily bans themselves helps them gamble less. Over 2,500 adults who self-excluded from online sports betting, poker, or horse racing were randomly assigned to either the standard procedure or one where ads were paused for 9 months. The goal was to see if the longer ad break reduced the amount of money lost to gambling.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,554 people

The number who actually took part.

Started

May 2022

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years or older * self-excluder during the recruitment period * Online sports betting * poker and horse racing player * account opened for at least 4 weeks * self-exclusion for 3 months or less (minimum 3 days). Exclusion Criteria: * Player who has objected to the use of his collected data when opening his account. * It's not the first self-exclusion of the inclusion period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gambling disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pathological gambling

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gambling disorder

Contacts and locations

Locations

  • Amandine LUQUIENS

    Nîmes, Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.